Search PubMed⌕ Search

SEARCH · Search PubMed

Results for “Policy”

Search indexed PubMed citations on genomics, clinical trials, systematic reviews and public health. Explore titles, authors and supplied subject terms, then open the PubMed record.

Quote a phrase for an exact phrase match. Source license links do not imply unrestricted reuse.

At least 793 records · Page 44Linked to original sources

Assessing the impact of patient care policies using simulation analysis.

Simulation models are ideal for assessing the performance of strategic, tactical, and operational policies for hospitals. Simulation can validate a proposed policy, uncover fallacies of a proposal, or determine the sensitivity of the response to a policy change. A simulation model was developed to analyze the complex interactions comprising patient placement processes, beginning with patient arrivals and continuing through discharge. The model reflects current and potential patient assignment policies at a major southeastern general hospital. The system developed was utilized to assess proposed policies for the hospital. The simulated results of the hospital policy proposals, as well as other proposals, demonstrate the usefulness of simulation analysis in hospital policy decision-making.

Bed Occupancy↗

Survey of the implementation of workplace alcohol and smoking policies among employers in Fife.

A survey of major employers in Fife shows that at present 33% of respondents have implemented written alcohol policies, while 40% have implemented written smoking policies. A total of 19% have both alcohol and smoking policies in place. The initiative for policy development appears to have arisen mainly from management, but trade unions and management have co-operated well during policy formulation. The majority of policies have been implemented for more than three years. A small number of companies in Fife appear to be interested in the development and implementation of written alcohol and smoking policies in the workplace.

Alcohol Drinking↗

Smoking in Ontario schools: does policy make a difference?

OBJECTIVE: Studies in other countries have shown that school tobacco control policy has potential to prevent smoking uptake in adolescents. Since no Canadian research has studied this association, we assessed the statistical link between school tobacco policy and smoking status in Ontario elementary and secondary schools. METHODS: We conducted secondary analysis of data collected using the School Smoking Profile, a cross-sectional, self-report questionnaire. School policy variables were formed from five survey items concerning students' perceptions of school tobacco control policy. Smoking status was determined through self-report measures which had been validated by carbon monoxide testing. Logistic regression models used school policy variables to explain smoking status in elementary and secondary schools, controlling for school location, school size, and student's grade level. RESULTS: The smoking policy variables, rules and enforcement, explained smoking status after controlling for other variables. In elementary schools, perceptions of stronger enforcement reduced the odds of being a smoker (OR = 0.39, CI99 = 0.34-0.44). In secondary schools, enforcement lost its protective effect (OR = 1.05, CI99 = 1.00-1.10). In addition, student perceptions that rules were strong were indicative of increased smoking in secondary schools (OR = 1.32, CI99 = 1.27-1.37). DISCUSSION: Strong enforcement of school tobacco control policy appears to be effective in elementary schools but is not as helpful in secondary schools. Secondary school policymakers should consider modifying their sanctions to avoid alienating smokers.

Adolescent↗

High level security policies for health care establishments.

Health Care Establishments (HCE) are today highly dependent upon Information and Communications Technologies (ICT). This increasing reliance upon ICT has stressed the need to foster security in Healthcare Information Systems (HIS). Security policies may have a significant contribution to this effort, but they could become the cause of portability and interoperability problems. Moreover, policies that fail to take into account all the aspects of HIS security, the legal and regulatory requirements, and the existence of several stakeholders may lead to ineffective or inefficient security measures. Policies of a special category, named Generic Security Policies (GSP), should be developed to provide policy-level harmonisation and guidance to policy-makers within HCE. Six such policies are comparatively reviewed herein.

Access to Information↗

[Women and family policy between ambivalence and implication].

The eighties mark the Québec government's setting up of a family policy. But all the facts indicate that this policy wavered between a family policy, a birth policy and a population policy. Women's groups and feminists, already reticent in dealing with traditional family and maternity institutions, were possessed with somewhat of an ambivalent attitude towards these policies mostly because of their fear of being trapped and undermined. All in all, it's the will to disseminate their point of view and to defend their interests that motivated women to get involved in these debates. The article concludes by advancing principles that should promote a family policy that is more sensitive to women's interests.

Attitude to Health↗

Social policy and drug safety.

Drug safety policy for the elderly says more by its relative silence and ambiguity than it could by any single affirmative set of rules and principles. The difficulties in developing such social policies embody the interaction of the complexities of each of three dimensions: social policy, which requires consensus on roles, responsibilities, and the sharing of costs; drug safety monitoring, which requires a maturing and evolving body of science, technology, and practice to converge; and geriatric pharmacology, about which the answers are only now beginning to materialize. The social forces of incomplete consensus, incomplete science, and incomplete technology beg for a solid public policy. However in the next breath they beg, yet more urgently, for the first step in such public policy, a step that remains to be taken and is of great urgency. All of those concerned with the goal of minimizing the morbidity and disability, regardless of the state of disease, in the elderly must collaborate to chart the course for each of these three forces to reach the level in which responsible social policy can be made. This will require a good faith collaboration among government, the pharmaceutical industry, the health professions, the university community, and patients or their advocates. Although the recommendations of the Melmon Commission for the creation of a "Center for Drug Safety," jointly funded by government, the industry, and the universities, may never be fulfilled and may not, in fact, be needed in bricks and mortar, certainly the spirit of such a center must be the essential first step. The ground rules--for collaboration, capacity building, nurturance, support, and professional development and technology, particularly linkage-extension--must similarly be discussed broadly in open forum. Otherwise, multiple empires, separate mutually incompatible systems, and epidemiologic squabbling will surely carry the day. Finally, research must be done better to define, understand, and address special problems of the elderly. In the end, it is this special population who must receive the unique attention of drug safety policies and their implementing systems. Just as the processes of health and of ill health need better understanding, so too must the processes of aging and their impacts upon drug risk be better understood. This research must go beyond the high-tech spheres of pharmacology and pharmacokinetics. The addition of epidemiologic analysis of risk factors for therapeutic misadventure (iatrogenic and self-induced) and for health status specific long- and short-term adverse drug experience will contribute substantially to drug safety in the elderly.

Aged↗

[The institutional policy concerning sexuality: the necessary transformation of the sexology paradigm].

An increasing number of hospitals and rehabilitation centres include sexuality in their mandate. Some of these establishments have developed a policy in this matter or would like to. Based on a study of recorded policies, the author discusses various aspects of these policies, including legitimacy, necessity, content and implementation. Most policies under study are built around the notion that sexuality is a problem. The policy is therefore designed as an instrument for normalization and social control. The author proposes another paradigm: that which envisions sexuality positively by emphasizing the need to improve one's quality of sex life. As a result, policies would be more attuned to the meaning of sexuality rather than to sexual norms and rules. The author argues that such a concept widens the scope of institutional policy, from sexuality-as-a-problem to sexuality-as-a-health-issue.

Health Policy↗

[Maastricht European social policy with special reference to questions concerning rehabilitation and disability topics].

A protocol annexed to the Maastricht Treaty of 7 February 1992, the agreement on social policy is instrumental in upgrading European social policy and in making it an integral part of the policy of the European Union. It is on the one hand oriented toward appropriate provisions to protect workers in the various EU member countries against disadvantage arising from developments in the economic sector, but on the other also seeks to counter the high level of unemployment currently at hand by fostering concrete action. European social policy, hence, is emphasizing employment policy initiatives including action aimed at occupational and social integration of disabled people, such as the HELIOS II action programme or the "Employment HORIZON" Community initiative. The Commission's notions of European social policy development in the forthcoming 1995-1999 period have been presented in the White Paper "European social policy, a way forward for the Union". The proposals contained in this White Paper are to be embodied in 1995 in a work programme of the European Commission.

Persons with Disabilities↗

Recent and current EPA good laboratory practice policy issues.

The Policy and Grants Division of the Office of Compliance Monitoring and specifically the Pesticides Enforcement Policy Branch (PEPB) of that division were active in policy issues affecting GLPs throughout the past year. Among the products have been a number of correspondences which have been made available to the regulated community--edited to preserve the confidentiality of persons writing to the agency--as "advisories." In addition, the PEPB actively worked with members of the regulated community to assist in their compliance with the GLPs. These two areas, GLP policy guidance during the last year and compliance-assistance efforts, are discussed below. Note that recently there have been organizational changes at EPA, and policy issues originally covered by the Pesticides Enforcement Policy Branch are now addressed by the new Agriculture Branch of the Agriculture and Ecosystems Division. This division is in the Office of Compliance of the newly formed Office of Enforcement and Compliance Assurance. This organizational change will not adversely affect EPA responsiveness on GLP policy matters.

Documentation↗

Differential perceptions of alcohol policy effectiveness.

Public support is crucial to sustained success for alcohol policies--but some may be supported precisely because they are expected to have the least impact on most drinkers. This paper offers an in-depth look at this "prevention dilemma," in an analysis of two alcohol control policies, higher alcohol taxes and health warning labels. In a recent national survey (n = 2000), respondents were asked about their perceptions of these policies' effects on moderate drinkers, on heavy drinkers, and on their drinking. Those who believed the label had affected their drinking were more likely to support the label policy, but the corresponding perception about higher prices' effect was not a significant predictor of support for higher taxes; heavier drinkers were less likely than others to endorse either policy. These data do not offer evidence that policy endorsement hinges on the belief that one's drinking is unaffected by the policy.

Alcohol Drinking↗

Workplace alcohol policies--are Scottish health boards exemplar employers?

The NHS in Scotland has been set the target of reducing the proportion of people drinking beyond the safe limits of alcohol by 20% by the year 2000. Much emphasis has been placed on development of local initiatives, including workplace alcohol policies, and guidelines were issued in 1989. In 1992 all Scottish health boards were asked for a copy of their policy and 13/15 replied (87%); 12 had policies (one in draft form only), and one did not have a policy. All regarded alcohol problems as a health issue and set out the procedures that managers should follow. However, only four addressed the use of alcohol on health board premises, and only one expressly banned drinking prior to duty and during breaks. Only four policies acknowledged the need to educate the employees about alcohol, and only three stated that the policy's effectiveness would be evaluated. This review of workplace alcohol policies shows that most Scottish health boards are not exemplar employers, and raises doubts as to whether the national target on alcohol consumption will be achieved.

Alcohol Drinking↗

Monitoring premature infants in car seats: implementing the American Academy of Pediatrics policy in a community hospital.

OBJECTIVES: In 1990, the American Academy of Pediatrics (AAP) Committee on Injury and Poison Prevention issued a policy statement which recommended that all infants born at less than 37 weeks gestational age be monitored in their car seat before discharge to identify infants at risk for apnea associated with car seat use. The objective of this report is to summarize the experience of a community hospital in implementing this recommendation, including: education of health professionals about the problem and its management, development of an effective hospital policy and procedure for testing at-risk infants, overcoming logistical difficulties for nursing staff who implement the policy, overcoming liability concerns, and summarizing the clinical results which we observed during a 15-month period. METHODS: MetroWest Medical Center, Framingham Union Campus is a community hospital with a Level II Neonatal Unit with approximately 2200 deliveries annually. Hospital procedures and policies were developed to implement the AAP policy for safe transportation of premature infants. Consequently, infants less than 37 weeks gestation at birth were monitored for a 90-minute observation period for oxygen saturation, apnea, or bradycardia in the car seat that they would be going home in from the nursery. RESULTS: Policies and procedures for car seat monitoring were instituted successfully during 15-month period. Sixteen of 87 (18.4%) monitored infants 26 to 36 weeks gestation had abnormal results. In addition, one 37-week gestational newborn who was monitored because of duskiness during feeds also became apneic and bradycardic in the car seat. CONCLUSIONS: A car seat monitoring program can be incorporated effectively into a Level II community hospital nursery discharge plan provided that appropriate medical staff policies, nursing procedures, and administrative support to deal with the logistics of the program is established. Our monitoring results are consistent with previous reports that premature infants are at risk of desaturation in a car seat. In addition, we have demonstrated that a full-term neonate may also be at risk if other evidence of desaturation (eg, duskiness during feedings) is observed.

Apnea↗

Smoking policy in pediatric hospitals and wards.

The American Academy of Pediatrics has recommended that pediatricians take the lead in banning cigarette smoking in all pediatric health care facilities. This study investigated the use of "nonsmoking" policies and their planned revisions, problems in enforcement, and any history of challenges to restrictive or lenient policies. The surveys were mailed to 329 hospitals affiliated with pediatric training programs as the institutions most likely to attempt to comply with the American Academy of Pediatrics recommendations. Representatives from 199 (60%) of the programs responded. The programs had a range of 12 to 350 pediatric beds in children's hospitals (27%), pediatric wards (69%), or general hospitals (4%). Only nine hospitals were "smoke-free," ie, having no designated indoor area for smoking. Another 35 had "restrictive" policies allowing smoking in only a single site or two preselected sites. Pediatric hospitals or wards were no more likely to have smoke-free policies than general hospitals. Existence of smoke-free or restrictive policies was unrelated to any other factor examined. Smoke-free and restrictive policies were more likely to be rigorously enforced but not more likely to engender formal challenges. Although almost all policies had been recently or are being revised, pediatric hospitals and wards remain remiss in controlling childhood smoke exposure.

Data Collection↗

Audit of antibiotic usage in medium-sized general hospital over an 11-year period. The impact of antibiotic policies.

The objective of the present study was to evaluate trends in antibiotic expenditure over an 11-year period (1982-1992) in a 370-bed district general hospital in Northern Ireland and to examine the impact of two separate antibiotic policies on antibiotic usage. A further objective was to examine the attitudes of prescribers to the second policy. Drug utilization review was used to collect information on antibiotic expenditure and usage before and after introduction of separate antibiotic policies in 1985 (not intensively monitored) and 1989 (intensively monitored). A main questionnaire was used to determine the attitudes of prescribers. The first policy (1985) showed no benefits with regard to the number of antibiotic entities stocked (45 before, 45 after), number of dosage units issued (9.3% increase) or expenditure (33.3% increase). The 1989 policy led to significant reductions in the number of antibiotic entities stocked (28.9%), number of antibiotics issued (11.9%) and expenditure (6.1%). Expenditure began to spiral upwards when active monitoring of the second policy was suspended. The majority of prescribers (87.2%) who responded to the questionnaire (56.5% response rate) felt that the 1989 policy made a positive contribution to antibiotic usage in the hospital.

Anti-Bacterial Agents↗

Effectiveness of a consultation intervention to promote tobacco control policies in Northwest Indian tribes: integrating experimental evaluation and service delivery.

A quasi-experimental replication of an intervention for promoting tobacco control policies in Northwest Indian tribes is described and the process of intervention including issues of collaboration among research institutions and Indian organizations is discussed. The policy intervention was evaluated using a pretest-posttest design wherein 20 tribes that had served as wait-list controls now received the intervention. The intervention comprised a tribal representative attending a kickoff orientation; follow-up visits to the tribes; distribution of tobacco policy workbooks; and phone call consultations. Policy status and stringency were assessed by means of telephone interviews with two key contacts per tribe, and by a count of enacted policies. There were significant pre-post changes in the primary outcome measure, a composite summary score of tobacco policy stringency, and changes were also reflected in enacted policies. The intervention effects observed were similar to those found in the prior randomized trial and suggest a robust, disseminable intervention. Much of the success achieved was attributed to the role of an Indian organization in planning the project and implementing the intervention and evaluation protocols.

Follow-Up Studies↗

Current national health insurance policies for thyroid cancer prophylactic surgery in the United States.

The efficacy of prophylactic thyroidectomy in patients with positive RET mutational analysis, familial thyroid cancer, or both has been reported. As cost has become critical to medical decision-making, this study was designed to evaluate currently existing coverage policies for prophylactic thyroidectomy. A confidential detailed cross-sectional nationwide survey of 481 medical directors from the American Association of Health Plans, Medicare, and Medicaid was conducted. Of the 150 respondents, 65% (n = 97) had 100,000 or more enrolled members, and 35% (n = 53) had fewer than 100,000 enrolled members. Only 9% of private plans have specific policies for coverage of prophylactic thyroidectomy for patients with a strong family history of thyroid cancer, 19% provided no coverage, and 72% had no policy. Only 9% of private plans have specific policies for patients with a known thyroid cancer genetic mutation, 12% provided no coverage, and 79% had no policy. Governmental carriers were less likely to provide coverage for prophylactic surgery: 4% for a strong family history and 6% for a genetic mutation. Altogether, 52% of government carriers provided no coverage for patients with a strong family history, and 50% provided no coverage in patients with a known genetic mutation; 44% of governmental carriers had no policy for either clinical scenario. Limited health insurance coverage for prophylactic thyroidectomy is offered in both private and governmental plans, with variations in coverage. As genetic testing becomes more widespread and with the potential identification of a gene predisposing to familial nonmedullary thyroid cancer, more uniform policies should be established to enable appropriate high risk candidates broader, equal coverage and access to these procedures.

Elective Surgical Procedures↗

Evolving research misconduct policies and their significance for physical scientists.

Scientific misconduct includes the fabrication, falsification, and plagiarism (FFP) of concepts, data or ideas; some institutions in the United States have expanded this concept to include "other serious deviations (OSD) from accepted research practice." It is the absence of this OSD clause that distinguishes scientific misconduct policies of the past from the "research misconduct" policies that should be the basis of future federal policy in this area. This paper introduces a standard for judging whether an action should be considered research misconduct as distinguished from scientific misconduct: by this standard, research misconduct must involve activities unique to the practice of science and must have the potential to negatively affect the scientific record. Although the number of cases of scientific misconduct is uncertain (only the NIH and the NSF keep formal records), the costs are high in terms of the integrity of the scientific record, diversions from research to investigate allegations, ruined careers of those eventually exonerated, and erosion of public confidence in science. Existing scientific misconduct policies vary from institution to institution and from government agency to government agency; some have highly developed guidelines that include OSD, others have no guidelines at all. One result has been that the federal False Claims Act has been used to pursue allegations of scientific misconduct. As a consequence, such allegations have been adjudicated in federal courts, rather than judged by scientific peers. The federal government is now establishing a first-ever research misconduct policy that would apply to all research funded by the federal government regardless of which agency funded the research or whether the research was carried out in a government, industrial or university laboratory. Physical scientists, who up to now have only infrequently been the subject of scientific misconduct allegations, must nonetheless become active in the debate over research misconduct policies and how they are implemented since they will now be explicitly covered by this new federal wide policy.

Costs and Cost Analysis↗

Effects of a prior-authorization policy for celecoxib on medical service and prescription drug use in a managed care Medicaid population.

BACKGROUND: Prior authorization (PA) is a poorly studied but commonly employed policy used by health care payers to manage the rising costs of pharmacy benefits. OBJECTIVE: The aim of this study was to evaluate the intended and unintended effects of a PA policy for celecoxib on pharmacy and medical-service utilization in a Medicaid managed-care organization. METHODS: This was a retrospective, interrupted time-series analysis of 22 monthly health-related utilization rates from January 1, 1999, to October 31, 2000. All Medicaid claims for CareOregon (a managed-care organization) and a fee-for-service program were reviewed. A model was constructed to evaluate changes in utilization of therapeutically related drug classes (eg, conventional nonsteroidal anti-inflammatory drugs [NSAIDs], gastrointestinal agents), office and emergency-department encounters, and hospitalizations before and after the PA policy was implemented on November 16, 1999. A secondary analysis evaluated these changes among a sample of prior NSAID users. RESULTS: After the PA policy was implemented, use of celecoxib was immediately reduced from 1.07 to 0.53 days' supply per person-year (58.9%; 95% CI, 50.0%-67.9%). The monthly rate of increase was also reduced (P < 0.001). Utilization changes were not observed in other drug classes. Similar changes were observed in the secondary analysis. An 18% (95% CI, 2.2%-33.9%) nonsignificant increase in emergency-department visits was observed in the entire sample after the PA policy was implemented. However, a similar change was not observed in the secondary analysis of prior NSAID users. No other changes in medical service encounters were noted after the PA policy was activated. CONCLUSIONS: This observational study found that celecoxib use was substantially reduced after the implementation of a PA policy. No important changes in use of other drug classes were detected. The overall increase in emergency-department visits--although not observed among previous NSAID users--should be explored on the individual level.

Adult↗